Global Viral Testing Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 97
Inquire Before Buying

Viral Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Viral Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Direct Fluorescent Antibody (DFA) Test

- Immunochromatographic Assay

- RT-PCR-Based Test

- Agglutination Assay

- Flow-Through Assay

- Solid-Phase Assay

Segment by Application

- Laboratory

- Hospital

- Home Care

- Academic Institute

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Roche

- Agilent Technologies

- Thermo Fisher Scientific

- QIAGEN International

- Lonza

- Wuxi Pharmatech (Cayman)

- Merck

- Eurofins Scientific

- General Electric

- Danaher

- Bio-Rad Laboratories

- BD

- Biospherix

- Novogene Corporation

- Sartorius

Global Viral Testing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Direct Fluorescent Antibody (DFA) Test
1.2.3 Immunochromatographic Assay
1.2.4 RT-PCR-Based Test
1.2.5 Agglutination Assay
1.2.6 Flow-Through Assay
1.2.7 Solid-Phase Assay
1.3 Market by Application
1.3.1 Global Viral Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Home Care
1.3.5 Academic Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Testing Market Perspective (2017-2028)
2.2 Viral Testing Growth Trends by Region
2.2.1 Viral Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Viral Testing Historic Market Size by Region (2017-2022)
2.2.3 Viral Testing Forecasted Market Size by Region (2023-2028)
2.3 Viral Testing Market Dynamics
2.3.1 Viral Testing Industry Trends
2.3.2 Viral Testing Market Drivers
2.3.3 Viral Testing Market Challenges
2.3.4 Viral Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Testing Players by Revenue
3.1.1 Global Top Viral Testing Players by Revenue (2017-2022)
3.1.2 Global Viral Testing Revenue Market Share by Players (2017-2022)
3.2 Global Viral Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Testing Revenue
3.4 Global Viral Testing Market Concentration Ratio
3.4.1 Global Viral Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Testing Revenue in 2021
3.5 Viral Testing Key Players Head office and Area Served
3.6 Key Players Viral Testing Product Solution and Service
3.7 Date of Enter into Viral Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Testing Breakdown Data by Type
4.1 Global Viral Testing Historic Market Size by Type (2017-2022)
4.2 Global Viral Testing Forecasted Market Size by Type (2023-2028)
5 Viral Testing Breakdown Data by Application
5.1 Global Viral Testing Historic Market Size by Application (2017-2022)
5.2 Global Viral Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Testing Market Size (2017-2028)
6.2 North America Viral Testing Market Size by Country (2017-2022)
6.3 North America Viral Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Viral Testing Market Size (2017-2028)
7.2 Europe Viral Testing Market Size by Country (2017-2022)
7.3 Europe Viral Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Testing Market Size (2017-2028)
8.2 Asia-Pacific Viral Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Viral Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Viral Testing Market Size (2017-2028)
9.2 Latin America Viral Testing Market Size by Country (2017-2022)
9.3 Latin America Viral Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Testing Market Size (2017-2028)
10.2 Middle East & Africa Viral Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Viral Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Viral Testing Introduction
11.1.4 Roche Revenue in Viral Testing Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Viral Testing Introduction
11.2.4 Agilent Technologies Revenue in Viral Testing Business (2017-2022)
11.2.5 Agilent Technologies Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Viral Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Viral Testing Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 QIAGEN International
11.4.1 QIAGEN International Company Detail
11.4.2 QIAGEN International Business Overview
11.4.3 QIAGEN International Viral Testing Introduction
11.4.4 QIAGEN International Revenue in Viral Testing Business (2017-2022)
11.4.5 QIAGEN International Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Viral Testing Introduction
11.5.4 Lonza Revenue in Viral Testing Business (2017-2022)
11.5.5 Lonza Recent Development
11.6 Wuxi Pharmatech (Cayman)
11.6.1 Wuxi Pharmatech (Cayman) Company Detail
11.6.2 Wuxi Pharmatech (Cayman) Business Overview
11.6.3 Wuxi Pharmatech (Cayman) Viral Testing Introduction
11.6.4 Wuxi Pharmatech (Cayman) Revenue in Viral Testing Business (2017-2022)
11.6.5 Wuxi Pharmatech (Cayman) Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Viral Testing Introduction
11.7.4 Merck Revenue in Viral Testing Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Viral Testing Introduction
11.8.4 Eurofins Scientific Revenue in Viral Testing Business (2017-2022)
11.8.5 Eurofins Scientific Recent Development
11.9 General Electric
11.9.1 General Electric Company Detail
11.9.2 General Electric Business Overview
11.9.3 General Electric Viral Testing Introduction
11.9.4 General Electric Revenue in Viral Testing Business (2017-2022)
11.9.5 General Electric Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Viral Testing Introduction
11.10.4 Danaher Revenue in Viral Testing Business (2017-2022)
11.10.5 Danaher Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Viral Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Viral Testing Business (2017-2022)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Viral Testing Introduction
11.12.4 BD Revenue in Viral Testing Business (2017-2022)
11.12.5 BD Recent Development
11.13 Biospherix
11.13.1 Biospherix Company Detail
11.13.2 Biospherix Business Overview
11.13.3 Biospherix Viral Testing Introduction
11.13.4 Biospherix Revenue in Viral Testing Business (2017-2022)
11.13.5 Biospherix Recent Development
11.14 Novogene Corporation
11.14.1 Novogene Corporation Company Detail
11.14.2 Novogene Corporation Business Overview
11.14.3 Novogene Corporation Viral Testing Introduction
11.14.4 Novogene Corporation Revenue in Viral Testing Business (2017-2022)
11.14.5 Novogene Corporation Recent Development
11.15 Sartorius
11.15.1 Sartorius Company Detail
11.15.2 Sartorius Business Overview
11.15.3 Sartorius Viral Testing Introduction
11.15.4 Sartorius Revenue in Viral Testing Business (2017-2022)
11.15.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Viral Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Direct Fluorescent Antibody (DFA) Test
Table 3. Key Players of Immunochromatographic Assay
Table 4. Key Players of RT-PCR-Based Test
Table 5. Key Players of Agglutination Assay
Table 6. Key Players of Flow-Through Assay
Table 7. Key Players of Solid-Phase Assay
Table 8. Global Viral Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Viral Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Viral Testing Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Viral Testing Market Share by Region (2017-2022)
Table 12. Global Viral Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Viral Testing Market Share by Region (2023-2028)
Table 14. Viral Testing Market Trends
Table 15. Viral Testing Market Drivers
Table 16. Viral Testing Market Challenges
Table 17. Viral Testing Market Restraints
Table 18. Global Viral Testing Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Viral Testing Market Share by Players (2017-2022)
Table 20. Global Top Viral Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Testing as of 2021)
Table 21. Ranking of Global Top Viral Testing Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Viral Testing Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Testing Product Solution and Service
Table 25. Date of Enter into Viral Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Testing Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Viral Testing Revenue Market Share by Type (2017-2022)
Table 29. Global Viral Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Viral Testing Revenue Market Share by Type (2023-2028)
Table 31. Global Viral Testing Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Viral Testing Revenue Market Share by Application (2017-2022)
Table 33. Global Viral Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Viral Testing Revenue Market Share by Application (2023-2028)
Table 35. North America Viral Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Viral Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Viral Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Viral Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Viral Testing Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Viral Testing Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Viral Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Viral Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Viral Testing Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Viral Testing Market Size by Country (2023-2028) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche Viral Testing Product
Table 48. Roche Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Agilent Technologies Company Detail
Table 51. Agilent Technologies Business Overview
Table 52. Agilent Technologies Viral Testing Product
Table 53. Agilent Technologies Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 54. Agilent Technologies Recent Development
Table 55. Thermo Fisher Scientific Company Detail
Table 56. Thermo Fisher Scientific Business Overview
Table 57. Thermo Fisher Scientific Viral Testing Product
Table 58. Thermo Fisher Scientific Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 59. Thermo Fisher Scientific Recent Development
Table 60. QIAGEN International Company Detail
Table 61. QIAGEN International Business Overview
Table 62. QIAGEN International Viral Testing Product
Table 63. QIAGEN International Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 64. QIAGEN International Recent Development
Table 65. Lonza Company Detail
Table 66. Lonza Business Overview
Table 67. Lonza Viral Testing Product
Table 68. Lonza Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 69. Lonza Recent Development
Table 70. Wuxi Pharmatech (Cayman) Company Detail
Table 71. Wuxi Pharmatech (Cayman) Business Overview
Table 72. Wuxi Pharmatech (Cayman) Viral Testing Product
Table 73. Wuxi Pharmatech (Cayman) Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 74. Wuxi Pharmatech (Cayman) Recent Development
Table 75. Merck Company Detail
Table 76. Merck Business Overview
Table 77. Merck Viral Testing Product
Table 78. Merck Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Eurofins Scientific Company Detail
Table 81. Eurofins Scientific Business Overview
Table 82. Eurofins Scientific Viral Testing Product
Table 83. Eurofins Scientific Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 84. Eurofins Scientific Recent Development
Table 85. General Electric Company Detail
Table 86. General Electric Business Overview
Table 87. General Electric Viral Testing Product
Table 88. General Electric Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 89. General Electric Recent Development
Table 90. Danaher Company Detail
Table 91. Danaher Business Overview
Table 92. Danaher Viral Testing Product
Table 93. Danaher Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 94. Danaher Recent Development
Table 95. Bio-Rad Laboratories Company Detail
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Viral TestingProduct
Table 98. Bio-Rad Laboratories Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 99. Bio-Rad Laboratories Recent Development
Table 100. BD Company Detail
Table 101. BD Business Overview
Table 102. BD Viral TestingProduct
Table 103. BD Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 104. BD Recent Development
Table 105. Biospherix Company Detail
Table 106. Biospherix Business Overview
Table 107. Biospherix Viral TestingProduct
Table 108. Biospherix Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 109. Biospherix Recent Development
Table 110. Novogene Corporation Company Detail
Table 111. Novogene Corporation Business Overview
Table 112. Novogene Corporation Viral TestingProduct
Table 113. Novogene Corporation Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 114. Novogene Corporation Recent Development
Table 115. Sartorius Company Detail
Table 116. Sartorius Business Overview
Table 117. Sartorius Viral TestingProduct
Table 118. Sartorius Revenue in Viral Testing Business (2017-2022) & (US$ Million)
Table 119. Sartorius Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Testing Market Share by Type: 2021 VS 2028
Figure 2. Direct Fluorescent Antibody (DFA) Test Features
Figure 3. Immunochromatographic Assay Features
Figure 4. RT-PCR-Based Test Features
Figure 5. Agglutination Assay Features
Figure 6. Flow-Through Assay Features
Figure 7. Solid-Phase Assay Features
Figure 8. Global Viral Testing Market Share by Application in 2021 & 2028
Figure 9. Laboratory Case Studies
Figure 10. Hospital Case Studies
Figure 11. Home Care Case Studies
Figure 12. Academic Institute Case Studies
Figure 13. Viral Testing Report Years Considered
Figure 14. Global Viral Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Viral Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Viral Testing Market Share by Region: 2021 VS 2028
Figure 17. Global Viral Testing Market Share by Players in 2021
Figure 18. Global Top Viral Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Testing as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Viral Testing Revenue in 2021
Figure 20. North America Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Viral Testing Market Share by Country (2017-2028)
Figure 22. United States Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Viral Testing Market Share by Country (2017-2028)
Figure 26. Germany Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Viral Testing Market Share by Region (2017-2028)
Figure 34. China Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Viral Testing Market Share by Country (2017-2028)
Figure 42. Mexico Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Viral Testing Market Share by Country (2017-2028)
Figure 46. Turkey Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Viral Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 49. Agilent Technologies Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 51. QIAGEN International Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 52. Lonza Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 53. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 55. Eurofins Scientific Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 56. General Electric Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 57. Danaher Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 59. BD Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 60. Biospherix Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 61. Novogene Corporation Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 62. Sartorius Revenue Growth Rate in Viral Testing Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs